Pospective care: A personalized, preventative approach to medicine

Pharmacogenomics

Volumn 7, Issue 1, 2006, Pages 5-9

  Snyderman, Ralph ^a   Yoedlono, Ziggy ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CLINICAL FEATURE; DECISION SUPPORT SYSTEM; DIAGNOSTIC IMAGING; DRUG METABOLISM; EDITORIAL; HAPLOTYPE; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH HAZARD; HISTOPATHOLOGY; HUMAN; MASS SPECTROMETRY; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL RESEARCH; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATIENT CARE; PATIENT CARE PLANNING; PHARMACOGENOMICS; PREDICTION; PREVENTIVE MEDICINE; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNITED STATES; GENOMICS; HEALTH CARE DELIVERY;

DECISION MAKING, COMPUTER-ASSISTED; DELIVERY OF HEALTH CARE; GENOMICS; HUMANS; PREVENTIVE MEDICINE;

EID: 33644877042     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.7.1.5     Document Type: Editorial

References (14)

1. Snyderman R, Williams RS: Prospective medicine: the next health care transformation. Acad. Med. 78(11), 1079-1084 (2003).
2. Williams RS, Willard HF, Snyderman R: Personalized health planning. Science 300 (5619), 549 (2003).
3. Langheier JM, Snyderman R: Prospective medicine: the role for genomics in personalized health planning. Pbarmacogenomics 5(1), 1-8 (2004).
4. Snyderman R: AAP Presidential Address: The AAP and the Transformation of Medicine. J. Clin. Invest. 114, 1169-1173 (2004).
5. Lai E: Application of SNP technologies in medicine: lessons learned and future challenges. Genome Res. 11(6), 927-929 (2001).
6. Lopes N, Vasudevan SS, Alvarez RJ, Binkley PF, Goldschmidt PJ: Pathophysiology of plaque instability: insights at the genomic level. Prog. Cardiovasc. Dis. 44(5), 323-338 (2002).
7. Shulzhenko N, Morgun A, Rampim GF: Monitoring of intragraft and peripheral blood TIRC7 expression as a diagnostic tool for acute cardiac rejection in humans. Hum. Immunol. 62(4), 342-347 (2001).
8. Seo D, Ginsburg GS: Genomic medicine: bringing biomarkers to clinical medicine. Curr. Opin. Chem. Biol. 9(4), 381-386 (2005).
9. Aebersold R, Mann M: Mass spectrometry-based proteomics. Nature 422(6928), 198-207 (2003).
10. de Lemos JA, Morrow DA: Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes. Rev. Cardiovasc. Med. 4(Suppl. 4), S37-S46 (2003).
11. Seo D, Ginsburg GS: Genomic medicine: bringing biomarkers to clinical medicine. Curr. Opin. Chem. Biol. 9(4), 381-386 (2005).
12. Brindle JT, Antti H, Holmes E et al.: Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nature Med. 8(12), 1439-1444 (2002).
13. Bell J: Predicting disease using genomics. Nature 429, 453-456 (2004).
14. Kajinami K, Okabayashi M, Sato R, Polisecki E, Schaefer EJ: Statin pharmacogenomics: what have we learned and what remains unanswered? Curr. Opin. Lipidol. 16(6), 606-613 (2005).